Newsroom

Sorted by: Latest

-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

MFA Financial, Inc. Announces Third Quarter Dividends on Series B Preferred Stock and Series C Preferred Stock

NEW YORK--(BUSINESS WIRE)--MFA Financial, Inc. (NYSE: MFA) (the “Company”) announced today that its Board of Directors has declared the payment of dividends on the Company’s outstanding 7.50% Series B Cumulative Redeemable Preferred Stock (the “Series B Preferred Stock”) and 6.50% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (the “Series C Preferred Stock”). In accordance with the terms of the Series B Preferred Stock, the Board of Directors has declared a preferred sto...
-

Tetra Tech Awarded $12.7 Million MCC Engineering Services Contracts

PASADENA, Calif.--(BUSINESS WIRE)--Tetra Tech, Inc. (NASDAQ: TTEK), a global provider of high-end technical and engineering services, Leading with Science® in water, environment, and sustainable infrastructure, announced today that the Millennium Challenge Corporation (MCC) selected Tetra Tech for two contracts totaling $12.7 million to provide independent engineering and technical services for critical infrastructure projects. Under concurrent 5-year contracts, Tetra Tech engineers and technic...
-

Chai Discovery Announces Collaboration with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery

SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery Announces Collaboration with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery...
-

Radiant Locks TRISO Fuel Supply Through Early 2030s

EL SEGUNDO, Calif.--(BUSINESS WIRE)--TRISO fuel agreement strengthens Radiant’s fully owned end-to-end supply chain and secures planned Kaleidos deployments through the early 2030s....
-

Apple Hospitality REIT Announces Monthly Distribution

RICHMOND, Va.--(BUSINESS WIRE)--Apple Hospitality REIT Announces Monthly Distribution...
-

Delclaux Partners Sues AST SpaceMobile for More Than $15 Million in Unpaid Contractual Finder's Fees

MIAMI--(BUSINESS WIRE)--Delclaux Partners Sues AST SpaceMobile for More Than $15 Million in Unpaid Contractual Finder's Fees...
-

Securities Fraud Investigation Into Aardvark Therapeutics, Inc. (AARD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Aardvark Therapeutics, Inc. (“Aardvark” or the “Company”) (NASDAQ: AARD) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON AARDVARK THERAPEUTICS, INC. (AARD), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS....
-

Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Aardvark Therapeutics, Inc. (“Aardvark” or the “Company”) (NASDAQ: AARD) investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AARDVARK THERAPEUTICS, INC. (AARD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your leg...
-

Insperity Declares Quarterly Dividend of $0.60

HOUSTON--(BUSINESS WIRE)--Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today announced that its board of directors has declared a quarterly cash dividend of $0.60 per share. The cash dividend will be paid on September 17, 2026, to all stockholders of record as of September 2, 2026. About Insperity Since 1986, Insperity’s mission has been to help businesses succeed so communities prosper. Offering a suite of...